Glycaemic Responses to Cracker Snacks

NCT ID: NCT01687569

Last Updated: 2013-05-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

27 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-09-30

Study Completion Date

2012-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether added ingredient affects glycaemic responses to a cracker snack.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glycaemic Response Measurements

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Cracker

Base cracker snack

Group Type PLACEBO_COMPARATOR

Control Cracker Snack

Intervention Type OTHER

Base cracker snack

Experimental Cracker Snack 1

Cracker snack containing test ingredient 1

Group Type EXPERIMENTAL

Experimental Cracker Snack 1

Intervention Type OTHER

Cracker snack containing test ingredient 1

Experimental Cracker Snack 2

Cracker snack containing test ingredient 2

Group Type EXPERIMENTAL

Experimental Cracker Snack 2

Intervention Type OTHER

Cracker snack containing test ingredient 2

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Control Cracker Snack

Base cracker snack

Intervention Type OTHER

Experimental Cracker Snack 1

Cracker snack containing test ingredient 1

Intervention Type OTHER

Experimental Cracker Snack 2

Cracker snack containing test ingredient 2

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female (not less than 40% Male)
* Aged 18 - 55 years
* Non Smokers
* Have a body mass index between 18.5 to 29.99 kg/m2
* Healthy, non-diabetic, no gastric bypass surgery
* Not allergic to wheat, mustard, dairy, or soy
* Have a fasting plasma glucose (finger-stick) \<100 mg/dl (\<5.5 mmol/L)
* Willing and able to provide written informed consent
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Reading Scientific Services Ltd.

INDUSTRY

Sponsor Role collaborator

Mondelēz International, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rungano Munyuki

Role: PRINCIPAL_INVESTIGATOR

Reading Scientific Services Limited

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Reading Scientific Services Limited (RSSL)

Reading, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P12-05774

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.